BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21419321)

  • 21. Hemolysate thioredoxin reductase and glutathione peroxidase activities correlate with serum selenium in a group of New Zealand men at high prostate cancer risk.
    Karunasinghe N; Ferguson LR; Tuckey J; Masters J
    J Nutr; 2006 Aug; 136(8):2232-5. PubMed ID: 16857846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between the GCG polymorphism of the selenium dependent GPX1 gene and the risk of young onset prostate cancer.
    Kote-Jarai Z; Durocher F; Edwards SM; Hamoudi R; Jackson RA; Ardern-Jones A; Murkin A; Dearnaley DP; Kirby R; Houlston R; Easton DF; Eeles R;
    Prostate Cancer Prostatic Dis; 2002; 5(3):189-92. PubMed ID: 12496980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of selenium supplementation on the distribution of selenium in plasma proteins of healthy subjects.
    Borglund M; Akesson B
    Int J Vitam Nutr Res; 1988; 58(1):97-102. PubMed ID: 3384592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of organic selenium supplement on glutathione peroxidase activities: a meta-analysis of randomized controlled trials].
    Jiang X; Dong J; Wang B; Yin X; Qin L
    Wei Sheng Yan Jiu; 2012 Jan; 41(1):120-3. PubMed ID: 22443071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
    Meyer F; Galan P; Douville P; Bairati I; Kegle P; Bertrais S; Estaquio C; Hercberg S
    Int J Cancer; 2005 Aug; 116(2):182-6. PubMed ID: 15800922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Red blood cell and plasma glutathione peroxidase activities and selenium concentration in patients with chronic kidney disease: a review.
    Zachara BA; Gromadzińska J; Wasowicz W; Zbróg Z
    Acta Biochim Pol; 2006; 53(4):663-77. PubMed ID: 17160142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plasma selenium concentration, glutathione peroxidase and glutathione S-transferase activities in patients with chronic liver diseases].
    Czuczejko J; Halota W; Zachara BA; Staubach-Topczewska E
    Pol Merkur Lekarski; 2002 Oct; 13(76):312-5. PubMed ID: 12557439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
    Adamowicz A; Trafikowska U; Trafikowska A; Zachara B; Manitius J
    Med Sci Monit; 2002 Mar; 8(3):CR202-5. PubMed ID: 11887037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial.
    Adams KF; Chen C; Newton KM; Potter JD; Lampe JW
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):644-8. PubMed ID: 15066931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Selenium metabolism and glutathione peroxidase activity of endurance athletes in rest and under exertion].
    Rokitzki L; Logemann E; Keul J
    Schweiz Z Sportmed; 1993 Mar; 41(1):21-7. PubMed ID: 8469946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a nutritional supplement containing vitamin E, selenium, vitamin c and coenzyme Q10 on serum PSA in patients with hormonally untreated carcinoma of the prostate: a randomised placebo-controlled study.
    Hoenjet KM; Dagnelie PC; Delaere KP; Wijckmans NE; Zambon JV; Oosterhof GO
    Eur Urol; 2005 Apr; 47(4):433-9; discussion 439-40. PubMed ID: 15774238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of lycopene supplementation in Tobago men with high prostate cancer risk.
    Bunker CH; McDonald AC; Evans RW; de la Rosa N; Boumosleh JM; Patrick AL
    Nutr Cancer; 2007; 57(2):130-7. PubMed ID: 17571945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostatic and peripheral blood selenium levels after oral supplementation.
    Gianduzzo TR; Holmes EG; Tinggi U; Shahin M; Mactaggart P; Nicol D
    J Urol; 2003 Sep; 170(3):870-3. PubMed ID: 12913719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma selenium and glutathione peroxidase in relation to cancer, angina pectoris and short-term mortality in 68-year-old men.
    Akesson B; Steen B
    Compr Gerontol A; 1987 Jun; 1(2):61-4. PubMed ID: 3453286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selenium, glutathione and glutathione peroxidases in blood of patients with chronic liver diseases.
    Czuczejko J; Zachara BA; Staubach-Topczewska E; Halota W; Kedziora J
    Acta Biochim Pol; 2003; 50(4):1147-54. PubMed ID: 14740001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deficient selenium status of a healthy adult Spanish population.
    Millán Adame E; Florea D; Sáez Pérez L; Molina López J; López-González B; Pérez de la Cruz A; Planells del Pozo E
    Nutr Hosp; 2012; 27(2):524-8. PubMed ID: 22732978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral selenium supplementation has no effect on prostate-specific antigen velocity in men undergoing active surveillance for localized prostate cancer.
    Stratton MS; Algotar AM; Ranger-Moore J; Stratton SP; Slate EH; Hsu CH; Thompson PA; Clark LC; Ahmann FR
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1035-43. PubMed ID: 20647337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer.
    Algotar AM; Stratton MS; Ahmann FR; Ranger-Moore J; Nagle RB; Thompson PA; Slate E; Hsu CH; Dalkin BL; Sindhwani P; Holmes MA; Tuckey JA; Graham DL; Parnes HL; Clark LC; Stratton SP
    Prostate; 2013 Feb; 73(3):328-35. PubMed ID: 22887343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood.
    Xia YM; Hill KE; Burk RF
    J Nutr; 1989 Sep; 119(9):1318-26. PubMed ID: 2795246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia.
    Hardell L; Degerman A; Tomic R; Marklund SL; Bergfors M
    Eur J Cancer Prev; 1995 Feb; 4(1):91-5. PubMed ID: 7537140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.